Contreras-Toledo D, Jimenez-Fonseca P, Lopez CL, Montes AF, Lopez Munoz AM, Vazquez Rivera F, Alonso V, Alcaide J, Salva F, Covela Rua M, Guillot M, Martin Carnicero A, Jimeno Mate R, Cameselle Garcia S, Asensio Martinez E, Gonzalez Astorga B, Fernandez-Diaz AB, Gonzalez Villaroel P, Virgili Manrique AC, Melian Sosa M, Alonso B, Cousillas Castineiras A, Castanon Lopez C, Aparicio J, Carmona-Bayonas A. Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist? Br J Cancer. 2024 Mar;130(5):777-787. doi: 10.1038/s41416-023-02563-w. Epub 2024 Jan 8. PubMed PMID: 38191609; PubMed Central PMCID: PMC10912758.
AÑO: 2024; IF: 6.8